BioLife Solutions Inc
NASDAQ:BLFS
BioLife Solutions Inc
NASDAQ:BLFS
Price:
20.76
USD
-1.42%
Market Closed
Market Cap:
$1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BioLife Solutions Inc
NASDAQ:BLFS
|
US |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
D
|
DoorDash Inc
NASDAQ:DASH
|
US |
|
Gap Inc
NYSE:GAP
|
US |
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
S
|
Synnex (Thailand) PCL
SET:SYNEX
|
TH |
|
US Physical Therapy Inc
NYSE:USPH
|
US |
|
Valneva SE
PAR:VLA
|
FR |
|
C
|
China Petroleum & Chemical Corp
XBER:CHU
|
CN |
|
P
|
Phinia Inc
NYSE:PHIN
|
US |
|
UGI Corp
NYSE:UGI
|
US |
|
NTG Nordic Transport Group AS
CSE:NTG
|
DK |
|
SAP SE
XETRA:SAP
|
DE |
Wall St Price Targets
BLFS Price Targets Summary
BioLife Solutions Inc
BioLife Solutions Inc
Wall Street analysts forecast BLFS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BLFS is 32.95 USD with a low forecast of 30.3 USD and a high forecast of 35.7 USD.
Lowest Forecast
Price Target
30.3
USD
46% Upside
Average Forecast
Price Target
32.95
USD
59% Upside
Highest Forecast
Price Target
35.7
USD
72% Upside
BioLife Solutions Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BLFS's stock price target?
Price Target
32.95
USD
32.95
USD
According to Wall Street analysts, the average 1-year price target for BLFS is 32.95 USD with a low forecast of 30.3 USD and a high forecast of 35.7 USD.
What is the Revenue forecast for BioLife Solutions Inc?
Projected CAGR
23%
23%
Over the last 13 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 23%.
